One of the most studied PTM is perhaps CyPD phosphorylation by glycogen synthase kinase 3β (GSK3β), a constitutively active Ser/Thr protein kinase that enhances PTP opening in cancer cells [42] and promotes CyPD binding to ANT [43]. This evidence concerns the gene PPIF and cancer.